Biomarker Revenue and Competitors

Location

Total Funding

Industry

Estimated Revenue & Valuation

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Endpoint	$48.5M	294	-6%	N/A	N/A
#2 eClinicalWorks	$872.9M	4300	N/A	N/A	N/A
#3 Allscripts	$1500M	5609	-10%	$100M	$2.2B
#4 Practice Fusion	$15.5M	111	-7%	$157.5M	N/A
#5 Vitera Healthca...	$16M	123	8%	N/A	N/A
#6 Office Ally	$36.4M	228	5%	N/A	N/A
#7 AdvancedMD	$124.5M	687	2%	N/A	N/A
#8 drchrono	$23.2M	154	-8%	$60.7M	N/A
#9 Modernizing Med...	$317.9M	1588	8%	$332.6M	$1B
#10 iPatientCare	$22.3M	140	N/A	N/A	N/A
#11 Welligent	$5.6M	48	N/A	N/A	N/A
#12 T-System	$306.2M	810	N/A	N/A	N/A
#13 Evident	$160.3M	475	N/A	N/A	N/A
#14 Nextech Systems	$79.4M	431	9%	$10.7M	N/A
#15 Meditab Softwar...	$80.3M	476	27%	N/A	N/A
#16 Procentive	$3.5M	30	-9%	N/A	N/A
#17 FutureNet	$62.4M	344	N/A	N/A	N/A
#18 iSALUS healthca...	$48.4M	163	N/A	N/A	N/A
#19 QHR Technologie...	$79.8M	440	-1%	N/A	N/A
#20 CliniComp Intl.	$26.8M	168	N/A	N/A	N/A

keywords:N/A

N/A

Total Funding

Number of Employees

$3.1M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Name	Title	Email/Phone
1 James Fallon	VP Engineering	Reveal Email/Phone

Outsourcing-Pharma recently spoke with David Liu, CEO of health technology company Sonde Health, about the potential of vocal biomarkers in...

"Our biomarker for early-stage Alzheimer's disease represents new thinking and is unique from the amyloid-beta and p-tau molecules that are...

Last year, Owkin received a $180 million investment from Sanofi in a deal that includes biomarker discovery. Owkin said that the investment made...

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 Discovery Digit...	$2.9M	20	-20%	N/A
#2 LendUp	$1.3M	20	5%	$361.5M
#3 Dor Technologie...	$2.3M	20	33%	$12.3M
#4 WorkPuls	$2M	20	N/A	N/A
#5 TrueVault	$2M	20	5%	$6.2M